2019-01-25 09:08 (Press release)
On 28 and 29 November 2018, the European Innovation Council (EIC) and Medtronic, a leader in the world of medical technology, gathered 20 companies to discuss the transformation of healthcare and promote business partnerships. VibroSense shared its solutions for early detection and diagnosis of... Read more »
2018-12-21 08:15 (News)
Preliminary results from studies conducted in collaboration with VibroSense Dynamics AB (VibroSense) research network indicate that the company's instruments and technology have a high potential for detecting early neurological changes in diabetes and the treatment of cancer with chemotherapy. The... Read more »
2018-10-03 18:09 (Press release)
For the first time ever, it has been shown that improved HbA1c (long-term blood sugar) is linked with improved tactile perception of feet in diabetic patients. The discovery was made in a study to evaluate the Multi-Frequency Vibrometry method and the VibroSense Meter® instrument. The result is... Read more »
2018-09-25 13:00 (Press release)
The senior specialist at Skåne University Hospital, Dr. Eero Lindholm, will present study results showing that it may be possible to reverse nerve damage in feet caused by diabetes by improved metabolic control. VibroSense Dynamics participates as an exhibitor at EASD in Hall 4 at booth 4J05.
Dr.... Read more »
2018-07-26 14:00 (Press release)
VibroSense Dynamics (VibroSense) has received a CE registration certificate of the company's new product VibroSense Meter II, by the Swedish Medicines Agency. The product is thus CE-marked and meets all requirements for sale, as a Class I medical device, within the EU. The instrument can also be... Read more »
2018-04-26 00:00 (Press release)
A study, published in the scientific journal PLOS ONE, reveals that 18 percent of examined children in Skåne, South of Sweden, with type 1 diabetes show initial signs of nerve damages in the feet, Diabetic Peripheral Neuropathy (DPN). The study also found that children, who used insulin pump... Read more »
2018-04-15 00:00 (Press release)
The previously communicated study at the clinic of Oncology, at Skåne University Hospital, has now been granted an ethical approval. The purpose of the study is to investigate the extent to which VibroSense Meter can be used to detect nerve damage (neuropathy) that occurs in the treatment of... Read more »
2018-03-18 00:00 (Press release)
VibroSense Dynamics (VibroSense) has received a first commercial purchase order targeting Chemotherapy-Induced Peripheral Neuropathy (CIPN). The department of Oncology at Linköping University Hospital has signed a “pay per use” agreement for the VibroSense Meter product.

The department of Oncology... Read more »
2017-12-05 00:00 (Press release)
The Brazilian Patent Office has approved VibroSense Dynamics patent application, which further strengthens the company's IP protection.
The approved patent protects VibroSense Dynamics technology to monitor the skin pressure force, i.e. how hard a patient presses his hand or foot on the vibrating... Read more »
2017-10-06 14:57 (Press release)
As a step in the preparation for launching VibroSense Meter® II, the combined hand- and foot-instrument, VibroSense Dynamics AB has started to cooperate with two retailers. These retailers are active in the UK, the Benelux countries and Germany.
VibroSense Dynamics has initiated a cooperation with... Read more »